AC-93253 iodide, a novel Src inhibitor, suppresses NSCLC progression by modulating multiple Src-related signaling pathways

Por Lai, Yi-Hua, Lin, Sih-Yin, Wu, Yu-Shan, Chen, Huei-Wen, Chen, Jeremy J. W.
Publicado no J Hematol Oncol (2017)

The positive inotropic agent DPI-201106 selectively reverses ABCB1-mediated multidrug resistance in cancer cell lines

Por Hsiao, Sung-Han, Murakami, Megumi, Yeh, Ni, Li, Yan-Qing, Hung, Tai-Ho, Wu, Yu-Shan, Ambudkar, Suresh. V., Wu, Chung-Pu
Publicado no Cancer Lett (2018)

Tyrphostin RG14620 selectively reverses ABCG2-mediated multidrug resistance in cancer cell lines

Por Wu, Chung-Pu, Hsiao, Sung-Han, Murakami, Megumi, Lu, Ming-Jie, Li, Yan-Qing, Hsieh, Chia-Hung, Ambudkar, Suresh. V., Wu, Yu-Shan
Publicado no Cancer Lett (2017)

SIS3, a specific inhibitor of Smad3 reverses ABCB1- and ABCG2-mediated multidrug resistance in cancer cell lines

Por Wu, Chung-Pu, Murakami, Megumi, Hsiao, Sung-Han, Liu, Te-Chun, Yeh, Ni, Li, Yan-Qing, Hung, Tai-Ho, Wu, Yu-Shan, Ambudkar, Suresh. V.
Publicado no Cancer Lett (2018)

Facilitating Anti-Cancer Combinatorial Drug Discovery by Targeting Epistatic Disease Genes

Por Quan, Yuan, Liu, Meng-Yuan, Liu, Ye-Mao, Zhu, Li-Da, Wu, Yu-Shan, Luo, Zhi-Hui, Zhang, Xiu-Zhen, Xu, Shi-Zhong, Yang, Qing-Yong, Zhang, Hong-Yu
Publicado no Molecules (2018)

Treatment of Spinocerebellar Ataxia with Mesenchymal Stem Cells: A Phase I/IIa Clinical Study

Por Tsai, Yun-An, Liu, Ren-Shyan, Lirng, Jiing-Feng, Yang, Bang-Hung, Chang, Chin-Hao, Wang, Yi-Chen, Wu, Yu-Shan, Ho, Jennifer Hui-Chun, Lee, Oscar K., Soong, Bing-Wen
Publicado no Cell Transplant (2017)